Update on the slow delayed rectifier potassium current (I Ks): Role in modulating cardiac function

Current Medicinal Chemistry

Volumn 19, Issue 9, 2012, Pages 1405-1420

  Liu, Zhenzhen ^a   Du, Lupei ^a   Li, Minyong ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

antiarrhythmic agents; cardiac arrhythmia; Chromanol293B; HMR1556; I Ks; I Ks activator; KCNE1; KCNQ1; KvLQT1; L 768; The slow delayed rectifier potassium current

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; 1,3 DIHYDRO 5 (2 FLUOROPHENYL) 3 (1H INDOL 3 YLMETHYL) 1 METHYL 2H 1,4 BENZODIAZEPIN 2 ONE; AZIMILIDE; BEPRIDIL; CETIRIZINE; CHLORTALIDONE; CHROMANOL 293B; CLOTRIMAZOLE; DOXORUBICIN; DRONEDARONE; EBASTINE; FLUNARIZINE; L 768763; MEFENAMIC ACID; MEFLOQUINE; N [3 HYDROXY 2,2 DIMETHYL 6 (4,4,4 TRIFLUOROBUTOXY)CHROMAN 4 YL] N METHYLMETHANESULFONAMIDE; NIFLUMIC ACID; NIP 142; PENTOBARBITAL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNQ1; PROPOFOL; QUINIDINE; RILMAKALIM; SEVOFLURANE; SIPATRIGINE; SPIRONOLACTONE; TERFENADINE; THIOPENTAL; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; DELIRIUM; DRUG SAFETY; DRUG STRUCTURE; EMOTIONAL STRESS; EXERCISE; HEART ARRHYTHMIA; HEART FUNCTION; HUMAN; LONG QT SYNDROME; NONHUMAN; POTASSIUM CURRENT; REVIEW; SEIZURE; SUDDEN DEATH; UPREGULATION;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; DELAYED RECTIFIER POTASSIUM CHANNELS; HEART; HUMANS; MUTATION; MYOCARDIUM; POTASSIUM;

EID: 84863270462     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712799462595     Document Type: Review

References (206)

1. Ks channel: potential antiarrhythmic agents. Curr Med Chem Cardiovasc Hematol Agents., 2003, 1, (3), 243-252.
2. Chugh, S.S.; Reinier, K.; Teodorescu, C.; Evanado, A.; Kehr, E.; Al Samara, M.; Mariani, R.; Gunson, K.; Jui, J., Epidemiology of sudden cardiac death: clinical and research implications. Prog. Cardiovasc. Dis., 2008, 51, (3), 213-228.
3. Walker, M., Antiarrhythmic drug research. Br. J. Pharmacol., 2006, 147, (S1), S222-S231. (Pubitemid 43077280)
4. Thireau, J.; Pasquié, J.L.; Martel, E.; Le Guennec, J.Y.; Richard, S., New drugs vs. old concepts: a fresh look at antiarrhythmics. Pharmacol. Ther., 2011, 132, (2), 125-145.
5. Greene, H.L.; Roden, D.M.; Katz, R.J.; Woosley, R.L.; Salerno, D.M.; Henthorn, R.W., The cardiac arrhythmia suppression trial: First CAST... then CAST-II. J. Am. Coll. Cardiol., 1992, 19, (5), 894-898.
6. Noble, D.; Tsien, R.W., Outward membrane currents activated in the plateau range of potentials in cardiac Purkinje fibres. J. Physiol., 1969, 200, (1), 205-231.
7. Ks) fails to lengthen rabbit ventricular muscle QTc and action potential duration. Br. J. Pharmacol., 2001, 132, (1), 101-110.
8. Sanguinetti, M.C.; Jurkiewicz, N.K., Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents. J. Gen. Physiol., 1990, 96, (1), 195-215. (Pubitemid 20227082)
9. Virag, L.; Iost, N.; Opincariu, M.; Szolnoky, J.; Szecsi, J.; Bogats, G.; Szenohradszky, P.; Varro, A.; Papp, J.G., The slow component of the delayed rectifier potassium current in undiseased human ventricular myocytes. Cardiovasc. Res., 2001, 49, (4), 790-797. (Pubitemid 32178382)
10. Chen, Y.H.; Xu, S.J.; Bendahhou, S.; Wang, X.L.; Wang, Y.; Xu, W.Y.; Jin, H.W.; Sun, H.; Su, X.Y.; Zhuang, Q.N., KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science, 2003, 299, (5604), 251-254.
11. Ks secondary to a mutation in KCNE5 associated with atrial fibrillation. Heart Rhythm, 2008, 5, (3), 427-435.
12. + current by dofetilide. Circul. Res., 1993, 72, (1), 75-83.
13. Sanguinetti, M.C.; Jurkiewicz, N.K.; Scott, A.; Siegl, P.K., Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Mechanism of action. Circul. Res., 1991, 68, (1), 77-84.
14. Hohnloser, S.H., Proarrhythmia with class III antiarrhythmic drugs: types, risks, and management. Am. J. Cardiol., 1997, 80, (8A), 82G-89G. (Pubitemid 27469748)
15. Hondeghem, L.; Snyders, D., Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence. Circulation, 1990, 81, (2), 686-690. (Pubitemid 20055978)
16. Waldo, A.L.; Camm, A.J.; deRuyter, H.; Friedman, P.L.; MacNeil, D.J.; Pauls, J.F.; Pitt, B.; Pratt, C.M.; Schwartz, P.J.; Veltri, E.P., Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet, 1996, 348, (9019), 7-12. (Pubitemid 26237238)
17. Torp-Pedersen, C.; M ller, M.; Bloch-Thomsen, P.E.; K ber, L.; Sand e, E.; Egstrup, K.; Agner, E.; Carlsen, J.; Videb k, J.; Marchant, B., Dofetilide in patients with congestive heart failure and left ventricular dysfunction. New Engl. J. Med., 1999, 341, (12), 857-865.
18. Ks Play a Role in the Reverse Rate Dependence of ClassIII Agents? Circul. Res., 1996, 78, (1), 26-37.
19. Grunnet, M., Repolarization of the cardiac action potential. Does an increase in repolarization capacity constitute a new anti-arrhythmic principle? Acta physiologica (Oxford, England), 2010, 198 Suppl 676, 1-48.
20. Maljevic, S.; Wuttke, T.V.; Seebohm, G.; Lerche, H., Kv7 channelopathies. Pflugers Arch., 2010, 460, (2), 277-288.
21. Jespersen, T.; Grunnet, M.; Olesen, S.P., The KCNQ1 potassium channel: from gene to physiological function. Physiology, 2005, 20, (6), 408-416.
22. Goldman, A.; Glasscock, E.; Yoo, J.; Chen, T.; Klassen, T.; Noebels, J., Arrhythmia in heart and brain: KCNQ1 mutations link epilepsy and sudden unexplained death. Sci. Transl. Med., 2009, 1, (2), 2ra6.
23. Sanguinetti, M.C.; Tristani-Firouzi, M., hERG potassium channels and cardiac arrhythmia. Nature, 2006, 440, (7083), 463-469.
24. Tamargo, J.; Caballero, R.; Gómez, R.; Valenzuela, C.; Delpón, E., Pharmacology of cardiac potassium channels. Cardiovasc. Res., 2004, 62, (1), 9-33. (Pubitemid 38326808)
25. Ks in dog ventricular muscle and Purkinje fibre repolarization. J. Physiol., 2000, 523, (1), 67-81.
26. Ks blockade at high heart rate in guinea pig and rabbit: implications for arrhythmogenesis in humans. Circulation, 2001, 104, (8), 951-956.
27. Stengl, M.; Volders, P.G.; Thomsen, M.B.; Spatjens, R.L.; Sipido, K.R.; Vos, M.A., Accumulation of slowly activating delayed rectifier potassium current (IKs) in canine ventricular myocytes. J. Physio.l, 2003, 551, (Pt 3), 777-786. (Pubitemid 37221072)
28. Ks contributes to the longer action potential of the M cell. Circul. Res., 1995, 76, (3), 351-365.
29. Xu, X.; Rials, S.J.; Wu, Y.; Salata, J.J.; Liu, T.; Bharucha, D.B.; Marinchak, R.A.; Kowey, P.R., Left ventricular hypertrophy decreases slowly but not rapidly activating delayed rectifier potassium currents of epicardial and endocardial myocytes in rabbits. Circulation, 2001, 103, (11), 1585-1590. (Pubitemid 32226269)
30. Ks) contribute to the differences in action potential duration in basal left ventricular myocytes in guinea-pig. Cardiovasc. Res., 1998, 40, (2), 322-331.
31. +current: a potential mechanism of the proarrhythmic effects of methanesulfonanilideclass III agents. Cardiovasc. Res., 1999, 43, (1), 135-147.
32. +currents in dogs with chronic complete atrioventricular block and acquired torsades de pointes. Circulation, 1999, 100, (24), 2455-2466.
33. Ks to ventricular repolarization in canine myocytes. Pflugers Arch., 2006, 452, (6), 698-706.
34. Ks to Canine Ventricular Repolarization. Circulation, 2003, 107, (21), 2753-2760.
35. Jost, N.; Virag, L.; Bitay, M.; Takacs, J.; Lengyel, C.; Biliczki, P.; Nagy, Z.; Bogats, G.; Lathrop, D.A.; Papp, J.G., Restricting excessive cardiac action potential and QT prolongation: a vital role for IKs in human ventricular muscle. Circulation, 2005, 112, (10), 1392-1399. (Pubitemid 41291763)
36. Ks restricts excessive beat-to-beat variability of repolarization during beta-adrenergic receptor stimulation. J. Mol. Cell. Cardiol., 2010, 48, (1), 122-130.
37. Xiao, L.; Xiao, J.; Luo, X.; Lin, H.; Wang, Z.; Nattel, S., Feedback remodeling of cardiac potassium current expression: a novel potential mechanism for control of repolarization reserve. Circulation, 2008, 118, (10), 983-992.
38. Marx, S.O.; Kurokawa, J.; Reiken, S.; Motoike, H.; D'Armiento, J.; Marks, A.R.; Kass, R.S., Requirement of a Macromolecular Signaling Complex for β Adrenergic Receptor Modulation of the KCNQ1-KCNE1 Potassium Channel. Science, 2002, 295, (5554), 496-499. (Pubitemid 34101639)
39. Matavel, A.; Lopes, C., PKC activation and PIP2 depletion underlie biphasic regulation of IKs by Gq-coupled receptors. J. Mol. Cell. Cardiol., 2009, 46, (5), 704-712.
40. Dong, M.Q.; Sun, H.Y.; Tang, Q.; Tse, H.F.; Lau, C.P.; Li, G.R., Regulation of human cardiac KCNQ1/KCNE1 channel by epidermal growth factor receptor kinase. Biochim. Biophys. Acta, 2010, 1798, (5), 995-1001.
41. + channels. Channels (Austin, Tex.), 2007, 1, (2), 124-134.
42. Ks Channel Complex Inhibits Drug Block. Circulation, 2003, 108, (2), 132-134.
43. 3. J. Biol. Chem., 2009, 284, (14), 9140-9146.
44. Chen, L.; Kass, R.S., A-Kinase Anchoring Protein 9 and IKs Channel Regulation. J. Cardiovasc. Pharmacol., 2011, 58, (5), 459-461.
45. + current via the AT1 receptor in guinea pig atrial myocytes. Circulation, 2006, 113, (10), 1278-1286.
46. 2, controls KCNQ1/KCNE1 voltage-gated potassium channels: a functional homology between voltage-gated and inward rectifier K+ channels. EMBO J., 2003, 22, (20), 5412-5421.
47. Suh, B.C.; Hille, B., Regulation of ion channels by phosphatidylinositol 4,5-bisphosphate. Curr. Opin. Neurobiol., 2005, 15, (3), 370-378. (Pubitemid 40806451)
48. + current by protein kinase C and protein kinase A. Circul. Res., 1998, 83, (10), 995-1002.
49. 2 interactions. Channels (Austin, Tex.), 2010, 4, (1), 3-11.
50. Seebohm, G.; Strutz-Seebohm, N.; Birkin, R.; Dell, G.; Bucci, C.; Spinosa, M.R.; Baltaev, R.; Mack, A.F.; Korniychuk, G.; Choudhury, A., Regulation of endocytic recycling of KCNQ1/KCNE1 potassium channels. Circul. Res., 2007, 100, (5), 686-692. (Pubitemid 46594883)
51. KS channel gating and assembly: impaired function in long-QT mutations. Circul. Res., 2006, 98, (8), 1055-1063.
52. + current in cardiac myocytes. Circul. Res., 2005, 96, (1), 64-72.
53. Asada, K.; Kurokawa, J.; Furukawa, T., Redox-and calmodulin-dependent S-nitrosylation of the KCNQ1 channel. J. Biol. Chem., 2009, 284, (9), 6014-6020.
54. + current by the serum and glucocorticoid-inducible kinase (SGK) isoforms. Pflugers Arch., 2003, 445, (5), 601-606.
55. Strutz-Seebohm, N.; Henrion, U.; Steinke, K.; Tapken, D.; Lang, F.; Seebohm, G., Serum-and glucocorticoid-inducible kinases (SGK) regulate KCNQ1/KCNE potassium channels. Channels (Austin, Tex.), 2009, 3, (2), 88-90.
56. Ks channels. Circul. Res., 2008, 103, (12), 1451-1457.
57. Jespersen, T.; Membrez, M.; Nicolas, C.S.; Pitard, B.; Staub, O.; Olesen, S.P.; Baro, I.; Abriel, H., The KCNQ1 potassium channel is down-regulated by ubiquitylating enzymes of the Nedd4/Nedd4-like family. Cardiovasc. Res., 2007, 74, (1), 64-74. (Pubitemid 46366952)
58. Ks in guinea-pig ventricular myocytes. Cardiovasc. Res., 2011, 91, (3), 429-436.
59. Takumi, T.; Ohkubo, H.; Nakanishi, S., Cloning of a membrane protein that induces a slow voltage-gated potassium current. Science, 1988, 242, (4881), 1042-1045.
60. + channel protein in mammalian cells and immunolocalization in guinea pig heart. Circul. Res., 1993, 73, (5), 968-973.
61. Lesage, F.; Attali, B.; Lakey, J.; Honore, E.; Romey, G.; Faurobert, E.; Lazdunski, M.; Barhanin, J., Are Xenopus oocytes unique in displaying functional IsK channel heterologous expression? Receptors Channels, 1993, 1, (2), 143-152.
62. Tristani-Firouzi, M.; Sanguinetti, M.C., Structural determinants and biophysical properties of HERG and KCNQ1 channel gating. J. Mol. Cell. Cardiol., 2003, 35, (1), 27-35. (Pubitemid 36286965)
63. Wang, Q.; Curran, M.E.; Splawski, I.; Burn, T.; Millholland, J.; VanRaay, T.; Shen, J.; Timothy, K.; Vincent, G.; De Jager, T., Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat. Genet., 1996, 12, (1), 17-23. (Pubitemid 26011314)
64. Sanguinetti, M.C.; Curran, M.E.; Zou, A.; Shen, J.; Spector, P.S.; Atkinson, D.L.; Keating, M.T., Coassembly of KvLQT1 and minK (IsK) proteins to form cardiac IKs potassium channel. Nature, 1996, 384, (6604), 80-83. (Pubitemid 26374592)
65. Ks cardiac potassium current. Nature, 1996, 384, (6604), 78-80.
66. Wu, D.; Delaloye, K.; Zaydman, M.A.; Nekouzadeh, A.; Rudy, Y.; Cui, J., State-dependent electrostatic interactions of S4 arginines with E1 in S2 during Kv7.1 activation. J. Gen. Physiol., 2010, 135, (6), 595-606.
67. Silva, J.R.; Pan, H.; Wu, D.; Nekouzadeh, A.; Decker, K.F.; Cui, J.; Baker, N.A.; Sept, D.; Rudy, Y., A multiscale model linking ion-channel molecular dynamics and electrostatics to the cardiac action potential. Proc. Natl. Acad. Sci. U. S. A., 2009, 106, (27), 11102-11106.
68. Tombola, F.; Pathak, M.M.; Isacoff, E.Y., How does voltage open an ion channel? Annu. Rev. Cell Dev. Biol., 2006, 22, 23-52.
69. Robbins, J., KCNQ potassium channels: physiology, pathophysiology, and pharmacology. Pharmacol. Ther., 2001, 90, (1), 1-19. (Pubitemid 32622837)
70. Labro, A.J.; Boulet, I.R.; Choveau, F.S.; Mayeur, E.; Bruyns, T.; Loussouarn, G.; Raes, A.L.; Snyders, D.J., The S4-S5 linker of KCNQ1 channels forms a structural scaffold with the S6 segment controlling gate closure. J. Biol. Chem., 2011, 286, (1), 717-725.
71. Choveau, F.S.; Rodriguez, N.; Ali, F.A.; Labro, A.J.; Rose, T.; Dahimène, S.; Boudin, H.; Le Hénaff, C.; Escande, D.; Snyders, D.J.; Charpentier, F.; Mérot, J.; Baró, I.; Loussouarn, G., KCNQ1 Channels Voltage Dependence through a Voltage-dependent Binding of the S4-S5 Linker to the Pore Domain. J. Biol. Chem., 2011, 286, (1), 707-716.
72. Ks channels. J. Physiol., 2008, 586, (17), 4179-4191.
73. Wiener, R.; Haitin, Y.; Shamgar, L.; Fernandez-Alonso, M.C.; Martos, A.; Chomsky-Hecht, O.; Rivas, G.; Attali, B.; Hirsch, J.A., The KCNQ1 (Kv7.1) COOH terminus, a multitiered scaffold for subunit assembly and protein interaction. J. Biol. Chem., 2008, 283, (9), 5815-5830.
74. Howard, R.J.; Clark, K.A.; Holton, J.M.; Minor Jr, D.L., Structural insight into KCNQ (Kv7) channel assembly and channelopathy. Neuron, 2007, 53, (5), 663-675. (Pubitemid 46283377)
75. Yus-Najera, E.; Santana-Castro, I.; Villarroel, A., The identification and characterization of a noncontinuous calmodulin-binding site in noninactivating voltage-dependent KCNQ potassium channels. J. Biol. Chem., 2002, 277, (32), 28545-28553. (Pubitemid 41079281)
76. Ghosh, S.; Nunziato, D.A.; Pitt, G.S., KCNQ1 assembly and function is blocked by long-QT syndrome mutations that disrupt interaction with calmodulin. Circul. Res., 2006, 98, (8), 1048-1054.
77. Xu, Q.; Minor, D.L., Jr., Crystal structure of a trimeric form of the Kv7.1 (KCNQ1) A-domain tail coiled-coil reveals structural plasticity and context dependent changes in a putative coiled-coil trimerization motif. Protein Sci., 2009, 18, (10), 2100-2114.
78. Dahimène, S.; Alcoléa, S.; Naud, P.; Jourdon, P.; Escande, D.; Brasseur, R.; Thomas, A.; Baró, I.; Mérot, J., The N-Terminal Juxtamembranous Domain of KCNQ1 Is Critical for Channel Surface Expression. Circul. Res., 2006, 99, (10), 1076-1083.
79. Rocheleau, J.M.; Gage, S.D.; Kobertz, W.R., Secondary structure of a KCNE cytoplasmic domain. J. Gen. Physiol., 2006, 128, (6), 721-729. (Pubitemid 44833382)
80. Kang, C.; Tian, C.; So nnichsen, F.D.; Smith, J.A.; Meiler, J.; George Jr, A.L.; Vanoye, C.G.; Kim, H.J.; Sanders, C.R., Structure of KCNE1 and Implications for How It Modulates the KCNQ1 Potassium Channel. Biochemistry (Mosc). 2008, 47, (31), 7999-8006.
81. Tian, C.; Vanoye, C.G.; Kang, C.; Welch, R.C.; Kim, H.J.; George Jr, A.L.; Sanders, C.R., Preparation, functional characterization, and NMR studies of human KCNE1, a voltage-gated potassium channel accessory subunit associated with deafness and long QT syndrome. Biochemistry (Mosc). 2007, 46, (41), 11459-11472. (Pubitemid 47585492)
82. Furukawa, T.; Ono, Y.; Tsuchiya, H.; Katayama, Y.; Bang, M.-L.; Labeit, D.; Labeit, S.; Inagaki, N.; Gregorio, C.C., Specific interaction of the potassium channel β-subunit minK with the sarcomeric protein T-cap suggests a T-tubule-myofibril linking system. J. Mol. Biol., 2001, 313, (4), 775-784. (Pubitemid 33063426)
83. Girmatsion, Z.; Biliczki, P.; Takac, I.; Schwerthelm, C.; Hohnloser, S.H.; Ehrlich, J.R., N-terminal arginines modulate plasma-membrane localization of Kv7.1/KCNE1 channel complexes. PLoS ONE, 2011, 6, (11), e26967.
84. Purtell, K.; Roepke, T.K.; Abbott, G.W., Cardiac arrhythmia and thyroid dysfunction: a novel genetic link. Int J Biochem Cell Biol, 2010, 42, (11), 1767-1770.
85. Ks to modulate channel activity. Proc. Natl. Acad. Sci. U. S. A., 2011, 108, (22), 9095-9100.
86. Melman, Y.F.; Um, S.Y.; Krumerman, A.; Kagan, A.; McDonald, T.V., KCNE1 binds to the KCNQ1 pore to regulate potassium channel activity. Neuron, 2004, 42, (6), 927-937. (Pubitemid 38798231)
87. Ks channel complex. Cell. Physiol. Biochem., 2011, 27, (5), 443-452.
88. Kspotassium channel by disulfide cross-linking of substituted cysteines. Proc. Natl. Acad. Sci. U. S. A., 2009, 106, (3), 743-748.
89. Ks Channelopathy. J. Membr. Biol., 2011, 1-20.
90. +channels. PLoS ONE, 2008, 3, (4), e1943.
91. Wu, D.; Pan, H.; Delaloye, K.; Cui, J., KCNE1 Remodels the Voltage Sensor of Kv7. 1 to Modulate Channel Function. Biophys. J., 2010, 99, (11), 3599-3608.
92. Osteen, J.D.; Gonzalez, C.; Sampson, K.J.; Iyer, V.; Rebolledo, S.; Larsson, H.P.; Kass, R.S., KCNE1 alters the voltage sensor movements necessary to open the KCNQ1 channel gate. Proc. Natl. Acad. Sci. U. S. A., 2010, 107, (52), 22710-22715.
93. Zheng, R.; Thompson, K.; Obeng-Gyimah, E.; Alessi, D.; Chen, J.; Cheng, H.; McDonald, T.V., Analysis of the interactions between the C-terminal cytoplasmic domains of KCNQ1 and KCNE1 channel subunits. Biochem. J, 2010, 428, (1), 75-84.
94. Lvov, A.; Gage, S.D.; Berrios, V.M.; Kobertz, W.R., Identification of a protein-protein interaction between KCNE1 and the activation gate machinery of KCNQ1. J. Gen. Physiol., 2010, 135, (6), 607-618.
95. + channel. Science, 2005, 309, (5736), 897-903.
96. Loussouarn, G.; Charpentier, F.; Mohammad-Panah, R.; Kunzelmann, K.; Baró, I.; Escande, D., KvLQT1 potassium channel but not IsK is the molecular target for trans-6-cyano-4-(N-ethylsulfonyl-N-methylamino)-3-hydroxy- 2,2-dimethyl-chromane. Mol. Pharmacol., 1997, 52, (6), 1131-1136. (Pubitemid 28013733)
97. Van Horn, W.D.; Vanoye, C.G.; Sanders, C.R., Working model for the structural basis for KCNE1 modulation of the KCNQ1 potassium channel. Curr. Opin. Struct. Biol., 2011, 21, (2), 283-291.
98. Ks current amplitude by KCNE2. J. Biol. Chem., 2009, 284, (24), 16452-16462.
99. Ks pore demonstrates two MinK subunits in each channel complex. Neuron, 2003, 40, (1), 15-23.
100. + channel complexes. Proc. Natl. Acad. Sci. U. S. A., 2008, 105, (5), 1478-1482.
101. sK channel. J. Biol. Chem., 1998, 273, (51), 34069-34074.
102. Nakajo, K.; Ulbrich, M.H.; Kubo, Y.; Isacoff, E.Y., Stoichiometry of the KCNQ1 - KCNE1 ion channel complex. Proc. Natl. Acad. Sci. U. S. A., 2010, 107, (44), 18862-18867.
103. Ks channel, complex indeed. Proc. Natl. Acad. Sci. U. S. A., 2010, 107, (44), 18751-18752.
104. Heitzmann, D.; Grahammer, F.; von Hahn, T.; Schmitt-Gräff, A.; Romeo, E.; Nitschke, R.; Gerlach, U.; Lang, H.J.; Verrey, F.; Barhanin, J.; Warth, R., Heteromeric KCNE2/KCNQ1 potassium channels in the luminal membrane of gastric parietal cells. J. Physiol., 2004, 561, (2), 547-557. (Pubitemid 39646542)
105. Schroeder, B.C.; Waldegger, S.; Fehr, S.; Bleich, M.; Warth, R.; Greger, R.; Jentsch, T.J., A constitutively open potassium channel formed by KCNQ1 and KCNE3. Nature, 2000, 403, (6766), 196-199. (Pubitemid 30050962)
106. Tinel, N.; Diochot, S.; Borsotto, M.; Lazdunski, M.; Barhanin, J., KCNE2 confers background current characteristics to the cardiac KCNQ1 potassium channel. EMBO J., 2000, 19, (23), 6326-6330.
107. Grunnet, M.; Jespersen, T.; Rasmussen, H.B.; Ljungstr m, T.; Jorgensen, N.K.; Olesen, S.P.; Klaerke, D.A., KCNE4 is an inhibitory subunit to the KCNQ1 channel. J. Physiol., 2002, 542, (1), 119-130.
108. Angelo, K.; Jespersen, T.; Grunnet, M.; Nielsen, M.S.; Klaerke, D.A.; Olesen, S.P., KCNE5 induces time-and voltage-dependent modulation of the KCNQ1 current. Biophys. J., 2002, 83, (4), 1997-2006.
109. Grahammer, F.; Herling, A.W.; Lang, H.J.; Schmitt-Gräff, A.; Wittekindt, O.H.; Nitschke, R.; Bleich, M.; Barhanin, J.; Warth, R., The cardiac K+ channel KCNQ1 is essential for gastric acid secretion. Gastroenterology, 2001, 120, (6), 1363-1371. (Pubitemid 32322310)
110. - Transport. J. Biol. Chem., 2010, 285, (10), 7165-7175.
111. Bendahhou, S.; Marionneau, C.; Haurogne, K.; Larroque, M.M.; Derand, R.; Szuts, V.; Escande, D.; Demolombe, S.; Barhanin, J., In vitro molecular interactions and distribution of KCNE family with KCNQ1 in the human heart. Cardiovasc. Res., 2005, 67, (3), 529-538. (Pubitemid 41019560)
112. Ks(KCNQ1-KCNE1) channel complex. FEBS J., 2008, 275, (6), 1336-1349.
113. Hedley, P.L.; Jørgensen, P.; Schlamowitz, S.; Wangari, R.; Moolman-Smook, J.; Brink, P.A.; Kanters, J.K.; Corfield, V.A.; Christiansen, M., The genetic basis of long QT and short QT syndromes: A mutation update. Hum. Mutat., 2009, 30, (11), 1486-1511.
114. Splawski, I.; Timothy, K.W.; Vincent, G.M.; Atkinson, D.L.; Keating, M.T., Molecular basis of the long-QT syndrome associated with deafness. New Engl. J. Med., 1997, 336, (22), 1562-1567. (Pubitemid 27231157)
115. Schwartz, P.J.; Priori, S.G.; Spazzolini, C.; Moss, A.J.; Vincent, G.M.; Napolitano, C.; Denjoy, I.; Guicheney, P.; Breithardt, G.; Keating, M.T., Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation, 2001, 103, (1), 89-95. (Pubitemid 32050441)
116. Villain, E.; Denjoy, I.; Lupoglazoff, J.M.; Guicheney, P.; Hainque, B.; Lucet, V.; Bonnet, D., Low incidence of cardiac events with β-blocking therapy in children with long QT syndrome. Eur. Heart J., 2004, 25, (16), 1405-1411. (Pubitemid 39078249)
117. Schmitt, N.; Schwarz, M.; Peretz, A.; Abitbol, I.; Attali, B.; Pongs, O., A recessive C-terminal Jervell and Lange-Nielsen mutation of the KCNQ1 channel impairs subunit assembly. EMBO J., 2000, 19, (3), 332-340. (Pubitemid 30072603)
118. Peroz, D.; Dahimène, S.; Baró, I.; Loussouarn, G.; Mérot, J., LQT1-associated Mutations Increase KCNQ1 Proteasomal Degradation Independently of Derlin-1. J. Biol. Chem., 2009, 284, (8), 5250-5256.
119. Schmitt, N.; Calloe, K.; Nielsen, N.H.; Buschmann, M.; Speckmann, E.J.; Schulze-Bahr, E.; Schwarz, M., The novel C-terminal KCNQ1 mutation M520R alters protein trafficking. Biochem. Biophys. Res. Commun., 2007, 358, (1), 304-310. (Pubitemid 46719117)
120. Sato, A.; Arimura, T.; Makita, N.; Ishikawa, T.; Aizawa, Y.; Ushinohama, H.; Kimura, A., Novel mechanisms of trafficking defect caused by KCNQ1 mutations found in long QT syndrome. J. Biol. Chem., 2009, 284, (50), 35122-35133.
121. Yamashita, F.; Horie, M.; Kubota, T.; Yoshida, H.; Yumoto, Y.; Kobori, A.; Ninomiya, T.; Kono, Y.; Haruna, T.; Tsuji, K.; Washizuka, T.; Takano, M.; Otani, H.; Sasayama, S.; Aizawa, Y., Characterization and Subcellular Localization of KCNQ1 with a Heterozygous Mutation in the C Terminus. J. Mol. Cell. Cardiol., 2001, 33, (2), 197-207. (Pubitemid 32537920)
122. Franqueza, L.; Lin, M.; Splawski, I.; Keating, M.T.; Sanguinetti, M.C., Long QT syndrome-associated mutations in the S4-S5 linker of KvLQT1 potassium channels modify gating and interaction with minK subunits. J. Biol. Chem., 1999, 274, (30), 21063-21070.
123. Seebohm, G.; Westenskow, P.; Lang, F.; Sanguinetti, M.C., Mutation of colocalized residues of the pore helix and transmembrane segments S5 and S6 disrupt deactivation and modify inactivation of KCNQ1 K+ channels. J. Physiol., 2005, 563, (2), 359-368. (Pubitemid 40360897)
124. Ks. J. Gen. Physiol., 2010, 135, (5), 433-448.
125. Kschannels. Cell. Physiol. Biochem., 2009, 24, (1-2), 11-16.
126. Thomas, D.; Khalil, M.; Alter, M.; Schweizer, P.A.; Karle, C.A.; Wimmer, A.B.; Licka, M.; Katus, H.A.; Koenen, M.; Ulmer, H.E., Biophysical characterization of KCNQ1 P320 mutations linked to long QT syndrome 1. J. Mol. Cell. Cardiol., 2010, 48, (1), 230-237.
127. Chouabe, C.; Neyroud, N.; Richard, P.; Denjoy, I.; Hainque, B.; Romey, G.; Drici, M.-D.; Guicheney, P.; Barhanin, J., Novel mutations in KvLQT1 that affect Iks activation through interactions with Isk. Cardiovasc. Res., 2000, 45, (4), 971-980. (Pubitemid 30089659)
128. Chen, L.; Marquardt, M.L.; Tester, D.J.; Sampson, K.J.; Ackerman, M.J.; Kass, R.S., Mutation of an A-kinase-anchoring protein causes long-QT syndrome. Proc. Natl. Acad. Sci. U. S. A., 2007, 104, (52), 20990-20995.
129. Splawski, I.; Tristani-Firouzi, M.; Lehmann, M.H.; Sanguinetti, M.C.; Keating, M.T., Mutations in the hminK gene cause long QT syndrome and suppress lKs function. Nat. Genet., 1997, 17, (3), 338-340. (Pubitemid 27476001)
130. Harmer, S.C.; Wilson, A.J.; Aldridge, R.; Tinker, A., Mechanisms of disease pathogenesis in long QT syndrome type 5. Am J Physiol Cell Physiol, 2010, 298, (2), C263-273.
131. Hong, K.; Piper, D.R.; Diaz-Valdecantos, A.; Brugada, J.; Oliva, A.; Burashnikov, E.; Santos-de-Soto, J.; Grueso-Montero, J.; Diaz-Enfante, E.; Brugada, P., De novo KCNQ1 mutation responsible for atrial fibrillation and short QT syndrome in utero. Cardiovasc. Res., 2005, 68, (3), 433-440. (Pubitemid 41566563)
132. Lundby, A.; Ravn, L.S.; Svendsen, J.H.; Olesen, S.P.; Schmitt, N., KCNQ1 mutation Q147R is associated with atrial fibrillation and prolonged QT interval. Heart Rhythm, 2007, 4, (12), 1532-1541. (Pubitemid 350187683)
133. Bellocq, C.; van Ginneken, A.C.G.; Bezzina, C.R.; Alders, M.; Escande, D.; Mannens, M.M.A.M.; Baró, I.; Wilde, A.A.M., Mutation in the KCNQ1 Gene Leading to the Short QT-Interval Syndrome. Circulation, 2004, 109, (20), 2394-2397. (Pubitemid 38679556)
134. KS' profile during both atrial and ventricular action potentials. J. Physiol. Pharmacol., 2010, 61, (6), 759-764.
135. Ks' channels incorporating the V307L KCNQ1 mutation. J. Physiol. Pharmacol., 2010, 61, (2), 123-131.
136. + conductance. Pflugers Arch., 1995, 429, (4), 517-530.
137. sK channels by chromanols - impact on the role of IsK channels in epithelia. FEBS Lett., 1996, 396, (2-3), 271-275.
138. Busch, A.E.; Suessbrich, H.; Waldegger, S.; Sailer, E.; Greger, R.; Lang,
139. + current, on repolarization in human and guinea pig ventricular myocytes. Cardiovasc. Res., 1998, 38, (2), 441-450.
140. Sun, Z.Q.; Thomas, G.P.; Antzelevitch, C., Chromanol 293B inhibits slowly activating delayed rectifier and transient outward currents in canine left ventricular myocytes. J. Cardiovasc. Electrophysiol., 2001, 12, (4), 472-478. (Pubitemid 32324664)
141. Du, X.L.; Lau, C.P.; Chiu, S.W.; Tse, H.F.; Gerlach, U.; Li, G.R., Effects of chromanol 293B on transient outward and ultra-rapid delayed rectifier potassium currents in human atrial myocytes. J. Mol. Cell. Cardiol., 2003, 35, (3), 293-300.
142. Ks-Channel Blockers. J. Med. Chem., 2001, 44, (23), 3831-3837.
143. Gögelein, H.; Brüggemann, A.; Gerlach, U.; Brendel, J.; Busch, A.E., Inhibition of IKs channels by HMR 1556. Naunyn-Schmiedeberg's Arch. Pharmacol., 2000, 362, (6), 480-488.
144. Bosch, R.F.; Schneck, A.C.; Csillag, S.; Eigenberger, B.; Gerlach, U.; Brendel, J.; Lang, H.J.; Mewis, C.; Gögelein, H.; Seipel, L.; Kühlkamp, V., Effects of the chromanol HMR 1556 on potassium currents in atrial myocytes. Naunyn-Schmiedeberg's Arch. Pharmacol., 2003, 367, (3), 281-288. (Pubitemid 36408010)
145. Selnick, H.G.; Liverton, N.J.; Baldwin, J.J.; Butcher, J.W.; Claremon, D.A.; Elliott, J.M.; Freidinger, R.M.; King, S.A.; Libby, B.E.; McIntyre, C.J., Class III Antiarrhythmic Activity in vivo by Selective Blockade of the Slowly Activating Cardiac Delayed Rectifier Potassium Current I Ks by (R)-2-(2, 4-Trifluoromethyl)-N-[2-oxo-5-phenyl-1-(2, 2, 2-trifluoroethyl)-2, 3-dihydro-1H-benzo [e][1, 4] diazepin-3-yl] acetamide. J. Med. Chem., 1997, 40, (24), 3865-3868. (Pubitemid 27512302)
146. Bock, M.G.; DiPardo, R.M.; Evans, B.E.; Rittle, K.E.; Whitter, W.L.; Veber, D.F.; Anderson, P.S.; Freidinger, R.M., Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260. J. Med. Chem., 1989, 32, (1), 13-16. (Pubitemid 19025279)
147. Ks-blocking class III antiarrhythmic agents. Bioorg. Med. Chem. Lett., 2003, 13, (6), 1165-1168.
148. Ks: potential for antiarrhythmic therapy. Curr. Med. Chem., 2004, 11, (1), 29-44.
149. Lloyd, J.; Schmidt, J.B.; Rovnyak, G.; Ahmad, S.; Atwal, K.S.; Bisaha, S.N.; Doweyko, L.M.; Stein, P.D.; Traeger, S.C.; Mathur, A., Design and Synthesis of 4-Substituted Benzamides as Potent, Selective, and Orally Bioavailable IKs Blockers. J. Med. Chem., 2001, 44, (23), 3764-3767. (Pubitemid 33051469)
150. Nakashima, H.; Gerlach, U.; Schmidt, D.; Nattel, S., In vivo electrophysiological effects of a selective slow delayed-rectifier potassium channel blocker in anesthetized dogs: potential insights into class III actions. Cardiovasc. Res., 2004, 61, (4), 705-714. (Pubitemid 38249469)
151. Ks-blocking agent HMR 1556 restores sinus rhythm and prevents heart failure in pigs with persistent atrial fibrillation. Basic Res. Cardiol., 2005, 100, (3), 270-278.
152. Ks Block by HMR 1556 Lowers Ventricular Defibrillation Threshold and Reverses the Repolarization Shortening by Isoproterenol Without Rate-Dependence in Rabbits. J. Cardiovasc. Electrophysiol., 2007, 18, (7), 750-756.
153. + current block by HMR 1556 increases dispersion of repolarization and promotes Torsades de Pointes in rabbit ventricles. Br. J. Pharmacol., 2008, 155, (8), 1185-1194.
154. Lynch Jr, J.J.; Houle, M.S.; Stump, G.L.; Wallace, A.A.; Gilberto, D.B.; Jahansouz, H.; Smith, G.R.; Tebben, A.J.; Liverton, N.J.; Selnick, H.G., Antiarrhythmic efficacy of selective blockade of the cardiac slowly activating delayed rectifier current, IKs, in canine models of malignant ischemic ventricular arrhythmia. Circulation, 1999, 100, (18), 1917-1922. (Pubitemid 29511146)
155. Ks and β-Adrenergic Receptor Blockade. J. Pharmacol. Exp. Ther., 2002, 302, (1), 283-289.
156. Ks-channel blocker HMR1556. Hearing Res., 2002, 172, (1-2), 145-150.
157. Ks) Has No Effect on Cochlear Structure and Function in vivo. Pharmacol. Toxicol., 2001, 88, (1), 45-50.
158. Salata, J.J.; Jurkiewicz, N.K.; Wang, J.; Evans, B.E.; Orme, H.T.; Sanguinetti, M.C., A novel benzodiazepine that activates cardiac slow delayed rectifier K+ currents. Mol. Pharmacol., 1998, 54, (1), 220-230. (Pubitemid 28337606)
159. sK channels expressed in Xenopus oocytes. Mol. Pharmacol., 1994, 46, (4), 750-753.
160. + channel complexes. PLoS ONE, 2009, 4, (1), e4236.
161. Gao, Z.; Xiong, Q.; Sun, H.; Li, M., Desensitization of chemical activation by auxiliary subunits: convergence of molecular determinants critical for augmenting KCNQ1 potassium channels. J. Biol. Chem., 2008, 283, (33), 22649-22658.
162. ks currents. J. Cardiovasc. Pharmacol., 2010, 55, (2), 145-152.
163. + channel currents through interacting with the K318 and V319 residues: A role of KCNE1 subunit. Eur. J. Pharmacol., 2010, 637, (1-3), 138-147.
164. Ks) potassium channels. Eur. J. Pharmacol., 2008, 590, (1-3), 317-321.
165. Zhang, Y.; Liu, Y.; Wang, T.; Li, B.; Li, H.; Wang, Z.; Yang, B., Resveratrol, a natural ingredient of grape skin: antiarrhythmic efficacy and ionic mechanisms. Biochem. Biophys. Res. Commun., 2006, 340, (4), 1192-1199. (Pubitemid 43083404)
166. Ks with benzodiazepine R-L3 in isolated guinea pig cardiomyocytes. J. Cardiovasc. Pharmacol., 2009, 54, (2), 169-177.
167. Ks corrects abnormal repolarization in rabbit models of acquired LQT2 and ventricular hypertrophy. Am J Physiol Heart Circ Physiol, 2002, 283, (2), H664-670.
168. Seebohm, G.; Pusch, M.; Chen, J.; Sanguinetti, M.C., Pharmacological activation of normal and arrhythmia-associated mutant KCNQ1 potassium channels. Circul. Res., 2003, 93, (10), 941-947. (Pubitemid 37433232)
169. Ks, in guinea-pig ventricular myocytes. Br. J. Pharmacol., 1999, 128, (8), 1733-1738.
170. Karam, R.; Marcello, S.; Brooks, R.R.; Corey, A.E.; Moore, A., Azimilide dihydrochloride, a novel antiarrhythmic agent. Am. J. Cardiol., 1998, 81, (6A), 40D-46D. (Pubitemid 28155909)
171. Turgeon, J.; Daleau, P.; Bennett, P.B.; Wiggins, S.S.; Selby, L.; Roden, D.M., Block of IKs, the slow component of the delayed rectifier K+ current, by the diuretic agent indapamide in guinea pig myocytes. Circul. Res., 1994, 75, (5), 879-886.
172. Fermini, B.; Jurkiewicz, N.K.; Jow, B.; Guinosso Jr, P.J.; Baskin, E.P.; Lynch Jr, J.J.; Salata, J.J., Use-dependent effects of the class III antiarrhythmic agent NE-10064 (azimilide) on cardiac repolarization: block of delayed rectifier potassium and L-type calcium currents. J. Cardiovasc. Pharmacol., 1995, 26, (2), 259-271.
173. VerNooy, R.A.; Mangrum, J.M., Azimilide, a novel oral class III antiarrhythmic for both supraventricular and ventricular arrhythmias. Curr. Drug Targets Cardiovasc. & Haematol. Disord., 2005, 5, (1), 75-84. (Pubitemid 40246726)
174. Conway, E.; Musco, S.; Kowey, P.R., New horizons in antiarrhythmic therapy: will novel agents overcome current deficits? Am. J. Cardiol., 2008, 102, (6A), 12H-19H.
175. Lombardi, F.; Borggrefe, M.; Ruzyllo, W.; Lüderitz, B., Azimilide vs. placebo and sotalol for persistent atrial fibrillation: the A-COMET-II (Azimilide-CardiOversion MaintEnance Trial-II) trial. Eur. Heart J., 2006, 27, (18), 2224-2231. (Pubitemid 44412838)
176. Towart, R.; Linders, J.; Hermans, A.N.; Rohrbacher, J.; van der Linde, H.J.; Ercken, M.; Cik, M.; Roevens, P.; Teisman, A.; Gallacher, D.J., Blockade of the IKs potassium channel: An overlooked cardiovascular liability in drug safety screening? J. Pharmacol. Toxicol. Methods, 2009, 60, (1), 1-10.
177. Guérard, N.; Traebert, M.; Suter, W.; Dumotier, B., Selective block of IKs plays a significant role in MAP triangulation induced by IKr block in isolated rabbit heart. J. Pharmacol. Toxicol. Methods, 2008, 58, (1), 32-40.
178. So, P.P.-S.; Hu, X.-D.; Backx, P.H.; Puglisi, J.L.; Dorian, P., Blockade of IKs by HMR 1556 increases the reverse rate-dependence of refractoriness prolongation by dofetilide in isolated rabbit ventricles. Br. J. Pharmacol., 2006, 148, (3), 255-263. (Pubitemid 43801172)
179. Curtis, M.J., Is cardiac IKs a relevant drug target? Cardiovasc. Res., 2004, 61, (4), 651-652. (Pubitemid 38249463)
180. Gómez, R.; Núñez, L.; Caballero, R.; Vaquero, M.; Tamargo, J.; Delpón, E., Spironolactone and its main metabolite canrenoic acid block hKv1.5, Kv4.3 and Kv7.1+minK channels. Br. J. Pharmacol., 2005, 146, (1), 146-161. (Pubitemid 43086104)
181. Bachmann, A.; Mueller, S.; Kopp, K.; Brueggemann, A.; Suessbrich, H.; Gerlach, U.; Busch, A.E., Inhibition of cardiac potassium currents by pentobarbital. Naunyn-Schmiedeberg's Arch. Pharmacol., 2002, 365, (1), 29-37. (Pubitemid 34045237)
182. sK) expressed in Xenopus oocytes. Naunyn-Schmiedeberg's Arch. Pharmacol., 1997, 356, (3), 404-409.
183. + current. J. Pharmacol. Sci., 2009, 110, (3), 334-343.
184. + current in guinea pig ventricular cells. J. Pharmacol. Sci., 2004, 95, (3), 363-373.
185. Tian, M.; Dong, M.Q.; Chiu, S.W.; Lau, C.P.; Li, G.R., Effects of the antifungal antibiotic clotrimazole on human cardiac repolarization potassium currents. Br. J. Pharmacol., 2006, 147, (3), 289-297.
186. Delpon, E.; Valenzuela, C.; Tamargo, J., Blockade of cardiac potassium and other channels by antihistamines. Drug Saf., 1999, 21, (Supplement 1), 11-18. (Pubitemid 30000235)
187. + currents in cardiac cells: comparison with terfenadine. Br. J. Pharmacol., 1998, 124, (4), 663-668.
188. + channel family by ebastine. J. Pharmacol. Exp. Ther., 1997, 281, (1), 233-244.
189. Salata, J.J.; Jurkiewicz, N.K.; Wallace, A.A.; Stupienski, R.F.; Guinosso, P.J.; Lynch, J.J., Cardiac Electrophysiological Actions of the Histamine H1-Receptor Antagonists Astemizole and Terfenadine Compared With Chlorpheniramine and Pyrilamine. Circul. Res., 1995, 76, (1), 110-119.
190. Kang, J.; Chen, X.-L.; Wang, L.; Rampe, D., Interactions of the Antimalarial Drug Mefloquine with the Human Cardiac Potassium Channels KvLQT1/minK and HERG. J. Pharmacol. Exp. Ther., 2001, 299, (1), 290-296. (Pubitemid 32905146)
191. Ks. Br. J. Pharmacol., 2010, 159, (1), 93-101.
192. Trepakova, E.S.; Dech, S.J.; Salata, J.J., Flunarizine is a highly potent inhibitor of cardiac hERG potassium current. J. Cardiovasc. Pharmacol., 2006, 47, (2), 211-220. (Pubitemid 44384059)
193. Daleau, P.; Turgeon, J., Triamterene inhibits the delayed rectifier potassium current (IK) in guinea pig ventricular myocytes. Circul. Res., 1994, 74, (6), 1114-1120.
194. Mancilla-Simbro, C.; Lopez, A.; Martinez-Morales, E.; Soto-Perez-de-Celis, E.; Millan-PerezPena, L.; Tsushima, R.; Salinas-Stefanon, E.M., Chlorthalidone inhibits the KvLQT1 potassium current in guinea-pig ventricular myocytes and oocytes from Xenopus laevis. Br. J. Pharmacol., 2008, 153, (3), 448-458.
195. Ks dual blockers. Bioorg. Med. Chem. Lett., 2009, 19, (5), 1477-1480.
196. Moller, C.; Netzer, R., Effects of estradiol on cardiac ion channel currents. Eur. J. Pharmacol., 2006, 532, (1-2), 44-49.
197. Namekata, I.; Tsuruoka, N.; Tsuneoka, Y.; Matsuda, T.; Takahara, A.; Tanaka, Y.; Suzuki, T.; Takahashi, T.; Iida-Tanaka, N.; Tanaka, H., Blocking Effect of NIP-142 on the KCNQ1/KCNE1 Channel Current Expressed in HEK293 Cells. Biol. Pharm. Bull., 2011, 34, (1), 153-155.
198. Gautier, P.; Guillemare, E.; Marion, A.; Bertrand, J.P.; Tourneur, Y.; Nisato, D., Electrophysiologic characterization of dronedarone in guinea pig ventricular cells. J. Cardiovasc. Pharmacol., 2003, 41, (2), 191-202. (Pubitemid 36135243)
199. Shimizu, A.; Niwa, R.; Lu, Z.; Honjo, H.; Kamiya, K., Effects of dronedarone on HERG and KCNQ1/KCNE1 channels. Environ. Med., 2003, 47, 48-50.
200. Gao, Z.; Milnes, J.T.; Choisy, S.; Leach, M.J.; Hancox, J.C.; James, A.F., The neuroprotective agent sipatrigine blocks multiple cardiac ion channels and causes triangulation of the ventricular action potential. Clin. Exp. Pharmacol. Physiol., 2005, 32, (12), 1088-1096. (Pubitemid 43906819)
201. 2+ channels to early afterdepolarizations induced by IKr and IKs channel suppression in guinea pig ventricular myocytes. J. Membr. Biol., 2008, 222, (3), 151-166.
202. Bett, G.C.L.; Morales, M.J.; Beahm, D.L.; Duffey, M.E.; Rasmusson, R.L., Ancillary subunits and stimulation frequency determine the potency of chromanol 293B block of the KCNQ1 potassium channel. J. Physiol., 2006, 576, (3), 755-767. (Pubitemid 44637881)
203. Lerche, C.; Bruhova, I.; Lerche, H.; Steinmeyer, K.; Wei, A.D.; Strutz-Seebohm, N.; Lang, F.; Busch, A.E.; Zhorov, B.S.; Seebohm, G., Chromanol 293B binding in KCNQ1 (Kv7.1) channels involves electrostatic interactions with a potassium ion in the selectivity filter. Mol. Pharmacol., 2007, 71, (6), 1503-1511. (Pubitemid 47010903)
204. Seebohm, G.; Chen, J.; Strutz, N.; Culberson, C.; Lerche, C.; Sanguinetti, M.C., Molecular determinants of KCNQ1 channel block by a benzodiazepine. Mol. Pharmacol., 2003, 64, (1), 70-77. (Pubitemid 36759819)
205. Du, L.P.; Li, M.Y.; Tsai, K.C.; You, Q.D.; Xia, L., Characterization of binding site of closed-state KCNQ1 potassium channel by homology modeling, molecular docking, and pharmacophore identification. Biochem. Biophys. Res. Commun., 2005, 332, (3), 677-687. (Pubitemid 40745168)
206. Banyasz, T.; Szentandrassy, N.; Toth, A.; Nanasi, P.P.; Magyar, J.; Chen-Izu, Y., Cardiac calmodulin kinase: a potential target for drug design. Curr. Med. Chem., 2011, 18, (24), 3707-3713.